Medtronic claims a 40% share of U.S. TAVI market with CoreValve

Medtronic CEO Omar Ishrak says the medical device company's CoreValve replacement heart valve has captured more than 40% of the U.S. transcatheter aortic valve implant market in just 2 quarters.

Edwards Lifesciences, Medtronic

News Well, Replacement Heart Valves, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/VFickb